An survey Study of Ekakushtha (Psoriasis) & Assessment of Dermato-toxicity And Efficacy of Ekakushthaari Lepa Against Psoriasis

An Etiopathological Study of Ekakushtha (Psoriasis) & Assessment of Dermato-toxicity And Efficacy of Ekakushthaari Lepa Against Psoriasis : An In-Vivo Study - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/07/090095

Enrollment

200

Registered

2025-07-03

Start date

Unknown

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L409- Psoriasis, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient with classical sign and symptoms of Ekakushtha like Aswednam, Matsyashakalvat, Mahavaastu. 2. Patients of either sex and age greater than 18-60 years.

Exclusion criteria

Exclusion criteria: 1. The patients suffering from severe systemic disorders. 2. Patient less than 18 years and more than 60 years of age. 3. Known case of skin malignancy. 4. Other skin diseases like fungal infections etc..

Design outcomes

Primary

Measure	Time frame
Strength of association of Etiopathological factors with Ekakushtha (Psoriasis)Timepoint: 4 weeks	—

Secondary

Measure	Time frame
Assessment of size of Psoriatic lesions on the completion of study.Timepoint: 4 weeks	—

Countries

India

Contacts

Public ContactDr Jamshed

National institute of ayurveda

drbks6@gmail.com9352311105

Outcome results